Catheter Precision (VTAK) Return on Sales (2017 - 2025)
Catheter Precision (VTAK) has disclosed Return on Sales for 8 consecutive years, with 2.62% as the latest value for Q3 2025.
- On a quarterly basis, Return on Sales rose 4030.0% to 2.62% in Q3 2025 year-over-year; TTM through Sep 2025 was 21.82%, a 746.0% increase, with the full-year FY2024 number at 32.15%, up 12752.0% from a year prior.
- Return on Sales was 2.62% for Q3 2025 at Catheter Precision, up from 38.12% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 616.0% in Q3 2021 to a low of 1918.93% in Q4 2022.
- A 5-year average of 246.9% and a median of 32.62% in 2024 define the central range for Return on Sales.
- Peak YoY movement for Return on Sales: plummeted -192728bps in 2022, then soared 191370bps in 2023.
- Catheter Precision's Return on Sales stood at 8.35% in 2021, then crashed by -23082bps to 1918.93% in 2022, then surged by 100bps to 5.23% in 2023, then plummeted by -219bps to 16.69% in 2024, then surged by 84bps to 2.62% in 2025.
- Per Business Quant, the three most recent readings for VTAK's Return on Sales are 2.62% (Q3 2025), 38.12% (Q2 2025), and 33.35% (Q1 2025).